EUCTR2010-022952-22-IT进行中(未招募)不适用
Acetytilcysteine Versus placebo for the prevention of Acute Reduction in Renal function after primary Angioplasty (NoVARA) - NoVARA
AZIENDA OSPEDALIERA MAGGIORE DELLA CARITA` DI NOVARA0 个研究点开始时间: 2010年12月17日最近更新:
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中(未招募)
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •patients with aged 18 years and 90 yearsa dmitted in hospital for acute coronary syndrome with persistente ST elevation and chest pain less than 12 hours
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- •shock cardiogenic, chronic dialisis, pregnancy, allergy to N-acetylcysteine, inability to obtain informed consent
研究者
相似试验
已完成
不适用
acetylcysteine as a Preventive Measure for Contrast Induced Nephropathy in Intensive Care Patients with Renal InsufficiencyRenal insufficiencyUrological and Genital DiseasesISRCTN43635237Academic Medical Centre (AMC) (Netherlands)246
已完成
不适用
se of N-Acetylcysteine for prevention of Heart-Lung machine associated liver complication in cardiac surgeryCTRI/2018/05/014024Dr Ram Manohar Lohia institute of Medical Sciences Lucknow66
已完成
2 期
Adjuvant N Acetylcysteine for Post Traumatuic Stress DisorderACTRN12618001784202Austin Health105
已完成
不适用
Evaluating N-acetylcysteine efficacy in the prevention of amphotericin B-induced nephrotoxicityFungal infections.Certain infectious and parasitic diseasesB37? B38 ?IRCT201107233449N8Tehran University of Medical Sciences60
已完成
不适用
Does prophylactic N-AcetylCysteine decrease incidence of contrast nephropathy in patients undergoing peripheral angiography?Contrast induced nephropathyUrological and Genital DiseasesNephropathyISRCTN35882618Cambridge University Hospital NHS Trust (UK)40
